Trial intelligence / Profile preview

Nab-paclitaxel plus S-1 in advanced pancreatic cancer

NCT03415802Phase 2Completed

Start
May 2015
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, tegafur in pancreatic cancer (PC). Started May 2015; status: completed.

02

Drugs

paclitaxeltegafur
03

Conditions

pancreatic cancer (PC)

Beyond the preview

Go deeper on NCT03415802.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03415802.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call